Sky Pharma

Business Data, Corporate Office and Headquarter Address

About

Sky Pharma is Drug Discovery in Japan that focus on developer business. Founded in 2019. They cover business area such as developer, regenerative medicine, low molecular weight compound, patient, drug discovery, induce pluripotent stem cell, affordable alternative, consumer.

Business Type

Drug Discovery

Country

Japan

Founded

2019
( 5 years old in 2024 )

Company Focus

Developer

Website

-

Corporate Office and Headquarter Office address:

6-1 Shimizukoji, Wakabayashi-ku
East Japan Real Estate Sendai First Building 1F
Sendai City
Japan

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developerregenerative medicinelow molecular weight compoundpatientdrug discoveryinduce pluripotent stem cellaffordable alternativeconsumer

* We use standard office opening hours in near Sky Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Sky Pharma Frequently Asked Questions

What or who is Sky Pharma?

Sky Pharma is Drug Discovery business from Japan that founded in 2019 (5 years old in 2024), Sky Pharma business is focusing on Developer.

Where is Sky Pharma headquarter and corporate office address?

Sky Pharma headquarter office and corporate office address is located in 6-1 Shimizukoji, Wakabayashi-ku East Japan Real Estate Sendai First Building 1F Sendai City Japan.

Where is Sky Pharma country origins?

Sky Pharma was founded in Japan.

What is Developer business focus on?

In 2024, Sky Pharma is currently focus on developer sector.

Developer Business Interest from Google Trend

Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Sky Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.